Home - Products - Others - Other Targets - GPI-1485

GPI-1485

CAS No. 186268-78-0

GPI-1485 ( GM1485 )

Catalog No. M28922 CAS No. 186268-78-0

GPI-1485 (GM1485) is a nonimmunosuppressive immunophilin ligand, promoting neurofunctional improvement and neural regeneration following stroke.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
5MG	147	Get Quote
10MG	222	Get Quote
25MG	410	Get Quote
50MG	605	Get Quote
100MG	860	Get Quote
200MG	Get Quote	Get Quote
500MG	Get Quote	Get Quote
1G	Get Quote	Get Quote

Group Booking Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

GPI-1485
Note

Research use only, not for human use.
Brief Description

GPI-1485 (GM1485) is a nonimmunosuppressive immunophilin ligand, promoting neurofunctional improvement and neural regeneration following stroke.
Description

GPI-1485 (GM1485) is a nonimmunosuppressive immunophilin ligand, promoting neurofunctional improvement and neural regeneration following stroke.(In Vitro):GPI-1485 induced cellular reprogramming and neural cell induction in normal human dermal fibroblasts (NHDF) .(In Vivo):GPI-1485 (5 mg/kg; intraperitoneal injection; 6-week period of daily) improved long-term neurological recovery in rats
Synonyms

GM1485
Pathway

Others
Target

Other Targets
Recptor

USP8
Research Area

——
Indication

——

Chemical Information

CAS Number

186268-78-0
Formula Weight

241.3
Molecular Formula

C12H19NO4
Purity

>98% (HPLC)
Solubility

——
SMILES

CCC(C)(C)C(=O)C(=O)N1CCC[C@H]1C(O)=O
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1.Zhiyu Li, et al. USP8 inhibitor and preparation method and application thereof. CN111138358A.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

t-Boc-N-amido-PEG8-a...

t-Boc-N-amido-PEG8-acid is a PEG derivative containing a terminal carboxylic acid and Boc-protected amino group.
NIBR-0213

NIBR-0213, a potent and selective S1P(1) antagonist, has efficacy in experimental autoimmune encephalomyelitis.
N-trans-caffeoylocto...

N-trans-Caffeoyltyramine has both arginase inhibitory property and antioxidant capacity.

Sign In Join Free